Previous Article | Next Article ![]()
Clinical and Diagnostic Laboratory Immunology, March 2001, p. 293-296, Vol. 8, No. 2
Department of Pediatrics, Satakunta Central
Hospital, Pori,1 and Department of
Biochemistry and Food Chemistry, University of
Turku,2 and Department of Pediatrics,
Turku University Hospital,3 Turku, Finland
Received 30 May 2000/Returned for modification 5 September
2000/Accepted 13 November 2000
The concentration of fecal mucin and the adhesion of specific
probiotics and their combinations in the intestinal mucus of infants
during and after rotavirus diarrhea and in healthy children were
determined. Mucus was prepared from fecal samples from 20 infants
during and after rotavirus diarrhea and from 10 healthy age-matched
children. Mucin concentration was determined, and the adhesion of five
probiotics
1071-412X/01/$04.00+0 DOI: 10.1128/CDLI.8.2.293-296.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Adherence of Probiotic Bacteria to Human Intestinal
Mucus in Healthy Infants and during Rotavirus Infection
Lactobacillus rhamnosus GG, Lactobacillus casei Shirota, Lactobacillus paracasei F19,
Lactobacillus acidophilus LA5, and Bifidobacterium
lactis Bb12
and their combinations was tested in vitro. The mean
concentrations of fecal mucin during and after rotavirus diarrhea, 15.2 and 14.1 mg/g, were comparable to that in healthy children, 14.9 mg/g.
The adherence of probiotics ranged from 1 to 34% in healthy subjects
as indicated for the following strains: L. rhamnosus GG,
34%; B. lactis Bb12, 31%; L. acidophilus LA5,
4%; L. paracasei F19, 3%; and L. casei
Shirota, 1% (P = 0.0001). The distinctive pattern of
probiotic adherence was not influenced by rotavirus diarrhea. The
adhesion of Bb12 in the presence of GG increased from 31 to 39% in
healthy infants (P = 0.018) and in episodes of
diarrhea increased from 26 to 44% (P = 0.001).
Rotavirus diarrhea does not decrease the production of fecal mucin or
with respect to the adhesion of probiotic bacteria tested in vitro.
Combination of specific probiotic strains may enhance adherence in a
synergistic manner. Optimal clinical application of these interactions
may offer novel therapeutic guidelines for the treatment and prevention
of gastrointestinal infections.
*
Corresponding author. Mailing address: Department of
Pediatrics, Satakunta Central Hospital, Pori, FIN-28500 Pori, Finland. Fax: 358-2-6276509. E-mail: marketta.juntunen{at}satshp.fi.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»